Quality
/ Purpose
This role is accountable for the end-to-end global process that ensures AI-enabled systems used in GxP contexts are validated/qualified and maintained in a state of control throughout their lifecycle, consistent with the company’s Quality Management System (QMS) expectations for global process ownership and controlled document architecture.
This role is validation/qualification-specific and operates in partnership with the existing global Business Process Owner (BPO) for Responsible Use of AI for GxP, who owns overarching responsible-use governance and user controls (e.g., human-in-the-loop expectations and usage constraints) and good understanding on the Global AI Regulatory requirements (EU Act, FDA).
Scope
Applies to AI systems, models, and tools (standalone or embedded) used to generate information or data supporting GxP-regulated activities, including the validation pathway that incorporates AI trustworthiness/credibility assessment and the associated templates and controlled records.
Key Responsibilities (Accountabilities)
1) Contributed and supports global AI validation/qualification process (end-to-end)
2) Own and maintain controlled documentation, templates, and required records
3) Governance integration & cross-functional alignment
4) Enable global deployment through training and guidance
5) Continuous improvement, metrics, and inspection readiness
Decision Rights / Authority
Key Interfaces (Stakeholders)
Required Qualifications
Education
Experience
Skills / Competencies

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes.
For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads.
🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines
🔗Global Privacy Statement Directory: www.amgen.com/dp
Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.